OSI Phase III Falls Short (OSIP, DNA)
OSI Pharmaceuticals Inc. (NASDAQ: OSIP) is getting hit hard in early trading this morning. The biotech has released data showing that a Phase III trial of Genentech's (NYSE: DNA) Avastin ...Read Full Story »
Posts related to ‘OSIP’
Read Full Story »
Genentech to Set Biotech Tone For Earnings Season (DNA, OSIP, SGEN, ABT, BIIB)
Thursday after the close, we’ll get to see earnings out of Genentech (NASDAQ: DNA). The estimates from First Call are $0.82 EPS on $3.11 billion in revenues. Next quarter estimates ...Read Full Story »
Top 10 Pre-Market Analyst Calls (AU, APOL, CLF, DRI, ETR, EXC, EXPD, F, MELI, OSIP, STX, WDC)
These are not all of the analyst calls out there affecting shares, but these are the top 10 analyst we are focusing on this Monday morning:Anglogold (NYSE: AU) Raised to ...Read Full Story »
Can Genentech Buck Its Long-Term Slide? (DNA, BIIB, NVS, OSIP, AMGN, BBH)
Genentech (NYSE: DNA) is set to report earnings after the close today. First Call has estimates pegged at $0.67 EPS on revenues of $2.97 Billion. This will also mark the ...Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (3376)
- Accounting (283)
- Activist Investor (250)
- ADR (534)
- Aerospace (111)
- After-Hours Activity (98)
- Agriculture (260)
- Airlines (303)
- Analyst Calls (2698)
- Annual Report (63)
- Apparel (208)
- Austerity (33)
- auto (15)
- Autos (1162)
- Bait Shop (91)
- Banking (1663)
- Bankruptcy (202)
- Biotech (726)
- Blogs (5)
- Bonds (384)
- Brokerage Firms (437)
- Buffett (301)
- Buffett Holdings (31)
- business and finance (27)
- Business Services (177)
- Cable Companies (128)
- Calendar (226)
- Casinos (67)
- Charts (107)
- China (857)
- Commodities (636)
- Compensation (309)
- Conglomerates (424)
- Consumer Electronics (1098)
- Consumer Goods (502)
- Corporate Governance (491)
- Cramer (728)
- Cult Stock (191)
- Currency (127)
- Defense (75)
- Defensive Stocks (116)
- Dividend (512)
- Drug companies (276)
- Earnings (2938)
- Earnings Warning (447)
- Economy (2465)
- Editor's Picks (458)
- Emerging Markets (195)
- Entertainment (570)
- ETF (532)
- Exchange (43)
- Exchange News (121)
- FDA (90)
- Financial Stocks (1182)
- Food (592)
- General (3668)
- Green Biz (878)
- Alternative Energy (838)
- Hardware (207)
- Healthcare (173)
- HI/LOW (711)
- Housing (679)
- Index (288)
- Industry (157)
- Technology (117)
- Semiconductors (38)
- Technology (117)
- Infrastructure (197)
- Insider Activity (217)
- International Markets (2079)
- Internet (1720)
- Interview (53)
- IPOs (998)
- Labor & Unions (451)
- Large Cap Stocks (129)
- Law (404)
- Luxury (156)
- Management Change (629)
- Market Close (159)
- Market Open (191)
- Market Roundups (40)
- Media (861)
- Medical (238)
- Mergers and Buy Outs (1867)
- Metals (460)
- Micro Cap (7)
- Most Actives (31)
- Mutual Funds (224)
- Nanotech (8)
- Newsletter (7)
- Nuclear (74)
- Oil & Gas (1855)
- Old Media (206)
- Options (106)
- OTC (25)
- PC Companies (613)
- Personal Finance (79)
- Pharmaceuticals (227)
- Politics (567)
- Polls (23)
- Pre-Market Activity (757)
- Press Digest (1350)
- Private Equity (432)
- Product Review (62)
- Regulation (472)
- REIT (89)
- Research (1586)
- Restatements (23)
- Retail (1255)
- Rumors (876)
- Satellite (273)
- SEC (164)
- Secondary Offering (529)
- Semiconductor (638)
- Shareholder Issues (475)
- Short Interest (326)
- Small Cap Stocks (20)
- Software (766)
- Special Report (125)
- Stock Buybacks (173)
- Stock Splits (60)
- Tax (86)
- Technical Analysis (99)
- Technology Companies (1340)
- Telecom (657)
- The Day (84)
- The Week (148)
- Tobacco (47)
- Trading Alert (960)
- Transports (250)
- Turnarounds (210)
- TV (86)
- Utilities (283)
- Value Investing (330)
- Video Games (204)
- Water (55)
- WiMAX (164)
- Wireless (966)
